arrow
Back
R

Robert S. Rosenson

Icahn School of Medicine at Mount Sinai

15H-index
45Paper Count
1.3KCitation Count
Published Papers 7
Publication Date
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
err2025-12-18
err0
PREAI
errFrederick J Raal; Jean Bergeron; Daniel Gaudet; Robert S Rosenson; David R Sullivan; Traci Turner; Robert A Hegele; Christie M Ballantyne; Joshua W Knowles; Nicholas J Leeper; Ira J Goldberg; Rong Zhou; Ma'an Muhsin; Jennifer Hellawell; James Hamilton; Gerald F Watts
errShare
errSave
Olpasiran, Oxidized Phospholipids, and Systemic Inflammatory Biomarkers Results From the OCEAN(a)-DOSE Trial
err2025-02-12
err2
PREAI
errRosenson, Robert S.; Lopez, J. Antonio G.; Gaudet, Daniel; Baum, Seth J.; Stout, Elmer; Lepor, Norman E.; Park, Jeong-Gun; Murphy, Sabina A.; Knusel, Beat; Wang, Jingying; Wilmanski, Tomaz; Wang, Huei; Wu, You; Kassahun, Helina; Sabatine, Marc S.; O'Donoghue, Michelle L.; OCEANa DOSE Trial Investigators
errShare
errSave
Inadequate Intensification of LDL-cholesterol lowering therapy after coronary revascularization: Insights from the GOULD registry
err2025-02-01
err0
errOAAI
errPeterson, Benjamin E.; Bhatt, Deepak L.; Ballantyne, Christie M.; Lemos, James A. de; Rosenson, Robert S.; Kosiborod, Mikhail N.; Cannon, Christopher P.
errShare
errSave
Underappreciated Opportunities for High-Density Lipoprotein Particles in Risk Stratification and Potential Targets of Therapy
err2015-02-24
err14
PREAI
errRosenson, Robert S.; Davidson, Michael H.; Le, Ngoc-Anh; Burkle, Jaime; Pourfarzib, Ray
errShare
errSave
Discordance between high non-HDL cholesterol and high LDL-cholesterol among US adults
err2014-01-01
err41
errOAAI
errKilgore, Meredith; Muntner, Paul; Woolley, J. Michael; Sharma, Pradeep; Bittner, Vera; Rosenson, Robert S.
errShare
errSave
errShare
errSave